New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.
about
SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferationChronic myelomonocytic leukemia prognostic classification and management: evidence base and current practice.Gene expression-based risk score in diffuse large B-cell lymphoma.Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients.Therapy for Chronic Myelomonocytic Leukemia in a New Era.Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.
P2860
New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
New prognostic markers, determ ...... omonocytic leukaemia patients.
@en
New prognostic markers, determ ...... omonocytic leukaemia patients.
@nl
type
label
New prognostic markers, determ ...... omonocytic leukaemia patients.
@en
New prognostic markers, determ ...... omonocytic leukaemia patients.
@nl
prefLabel
New prognostic markers, determ ...... omonocytic leukaemia patients.
@en
New prognostic markers, determ ...... omonocytic leukaemia patients.
@nl
P2093
P2860
P1476
New prognostic markers, determ ...... omonocytic leukaemia patients.
@en
P2093
Anthony Boureux
David Piquemal
Elias Bou Samra
Eric Jourdan
Fabienne Vacheret
Florence Rufflé
Jean Chiesa
Jérôme Moreaux
Thierry Lavabre-Bertrand
Thérèse Commes
P2860
P304
P356
10.1111/J.1365-2141.2012.09069.X
P407
P50
P577
2012-03-06T00:00:00Z